ARTICLE | Company News
FDA panel backs Guerbet imaging agent
February 16, 2013 1:30 AM UTC
FDA's Medical Imaging Drugs Advisory Committee unanimously recommended approval of Dotarem gadoterate meglumine from Guerbet S.A. (Euronext:GBT) to detect and visualize areas with disruption of the bl...